Verrica Pharmaceuticals (NASDAQ:VRCA – Free Report) had its price objective hoisted by HC Wainwright from $11.00 to $12.00 in a report issued on Thursday morning, Marketbeat.com reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Verrica Pharmaceuticals’ FY2026 earnings at $0.45 EPS. Several other equities research analysts […]
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA – Get Free Report) CEO Ted White sold 50,677 shares of the business’s stock in a transaction that occurred on Monday, July 24th. The stock was sold at an average price of $4.83, for a total transaction of $244,769.91. Following the completion of the sale, the chief executive officer now owns […]
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA – Get Free Report) insider Christopher G. Hayes sold 33,789 shares of the stock in a transaction on Monday, July 24th. The stock was sold at an average price of $4.83, for a total transaction of $163,200.87. Following the transaction, the insider now directly owns 81,925 shares in the company, valued […]
Jefferies Financial Group started coverage on shares of Verrica Pharmaceuticals (NASDAQ:VRCA – Get Rating) in a research report sent to investors on Wednesday morning, The Fly reports. The firm issued a buy rating and a $10.00 price objective on the stock. Jefferies Financial Group also issued estimates for Verrica Pharmaceuticals’ Q1 2023 earnings at ($0.20) […]